Anxiety News and Research

Latest Anxiety News and Research

Majority of long-term cancer survivors do not have access to personalized care services

An increasing number of people are surviving cancer, but many do not receive the services and support they need in the long term, Macmillan Cancer Support has said.

8 Jan 2010

Study reveals multiple ultrasound scans are more pronounced in low-risk pregnancies

Current use of prenatal ultrasounds in women with singleton pregnancies is 55% greater than in 1996, even in low-risk pregnancies. More than one-third (37%) of pregnant women now receive 3 or more ultrasound tests in the second and third trimesters of a given pregnancy, found an article http://www.cmaj.ca/embargo/cmaj090979.pdf in CMAJ (Canadian Medical Association Journal) www.cmaj.ca.

6 Jan 2010

Findings suggest abuse is a risk factor for chronic headache

Researchers from the American Headache Society's Women's Issues Section Research Consortium found that incidence of childhood maltreatment, especially emotional abuse and neglect, are prevalent in migraine patients.

5 Jan 2010

VELCADE sNDA receives FDA approval

Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE, which expands the label to include long-term (median follow-up 36.7 months) overall survival (OS) data from the landmark VISTA trial and provides specific dosing recommendations for patients with hepatic impairment. The VISTA trial examined the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).

5 Jan 2010

Talampanel slows progression of amyotrophic lateral sclerosis

A drug already used to treat symptoms of epilepsy has potential to slow the muscle weakening that comes with amyotrophic lateral sclerosis (ALS), scientists report after completing a Phase II clinical trial-an early, small-scale test to show if the drug works and continues to be safe.

5 Jan 2010

Impending job cuts raises anxiety at Peterborough Regional Health Centre

The Central East LHIN, which oversaw a peer review that resulted in 220 job cuts in the Rouge Valley Healthcare system is deliberately downplaying the potential impact of the same process in Peterborough, says the union representing 540 employees at the Peterborough Regional Health Centre.

4 Jan 2010

WDI utilizes DXA analysis for fitness and weight management programs

Women's Digital Imaging of Ridgewood (WDI), has begun using Dual Energy X-ray Absorptiometry (DXA), a technology developed to screen for osteoporosis (bone loss), to measure body fat in patients who want a more accurate method of establishing goals and measuring results for weight management and fitness programs.

4 Jan 2010

Sharing Miracles: A TV program that features inspirational stories of real patients

Major League Baseball slugger Aaron Boone will be featured on January's episode of Sharing Miracles - a 30-minute public affairs television program that tells the compelling and inspirational stories of real patients. Sharing Miracles airs every week on more than 300 television stations nationwide.

31 Dec 2009

Ford and MIT explore automotive technology solutions to reduce driver stress

As Americans fight through the most stressful time of the year, Ford Motor Company and the Massachusetts Institute of Technology (MIT) are embarking on a plan to study driver workload and identify new opportunities to use in-vehicle technologies to improve driver safety by lowering stress.

31 Dec 2009

Overview of grief

A death of a loved one, a job loss, the end of a marriage, an illness or disability. Everyone faces losses and grief, but the toll that grief can take on the mind and body can catch many people by surprise.

30 Dec 2009

CORE, a biopsychosocial treatment center for weight loss

Earlier this month, leaders in the treatment of weight related disorders and psychiatry joined forces under the Comprehensive Obesity Recovery Effort (CORE, LLC).

30 Dec 2009

First animal model for studying schizophrenia

Scientists have created what appears to be a schizophrenic mouse by reducing the inhibition of brain cells involved in complex reasoning and decisions about appropriate social behavior.

29 Dec 2009

CAMFT encourages people to focus on emotional health in 2010

While most New Year's resolutions revolve around changing your outward appearance by losing weight or hitting the gym, the California Association of Marriage and Family Therapists (CAMFT) encourages people to rethink their New Year's resolutions this year to focus inward on their emotional health in 2010.

29 Dec 2009

Test tube experiments show slight changes in protein chemistry can eliminate Huntington's disease in mice

In Huntington's disease, a mutated protein in the body becomes toxic to brain cells. Recent studies have demonstrated that a small region adjacent to the mutated segment plays a major role in the toxicity. Two new studies supported by the National Institutes of Health show that very slight changes to this region can eliminate signs of Huntington's disease in mice.

28 Dec 2009

PHT comments on FDA's PRO Final Guidance

PHT Corporation, the leading provider of ePRO (electronic patient reported outcome) solutions used in more than 400 clinical trials worldwide, commented on the FDA’s recent release of a final guidance almost four years following a Draft Guidance on the topic. The Final Guidance is entitled: Guidance for Industry, Patient-Reported Outcomes Measures: Use in Medical Product Development to Support Labeling Claims.

24 Dec 2009

FDA issues Pfizer a Complete Response letter for Lyrica GAD monotherapy treatment

Pfizer Inc. announced today that the Food and Drug Administration (FDA) issued a Complete Response letter regarding the company’s New Drug Application (NDA) for Lyrica® (pregabalin) capsules CV as a monotherapy treatment for generalized anxiety disorder (GAD). The FDA determined that the data contained in the NDA were insufficient to support approval.

24 Dec 2009

New energy receptor theory of brain function

Dr. Mitchell Earl Gibson, best-selling author, board-certified physician, and CEO of Tybro Publications, has proposed a new energy receptor theory of brain function that might explain the efficacy of mantras and prayer in human illness.

24 Dec 2009

GI Dynamics' EndoBarrier non-surgical type 2 diabetes therapy receives European CE mark approval

GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that it has received European CE mark approval for the EndoBarrier™, a non-surgical therapy to treat type 2 diabetes and obesity. The CE marking (an acronym for the French "Conformite Europeenne") certifies that a product has met EU requirements for marketing in Europe. Clinical trials involving more than 270 patients have demonstrated the significant weight loss and diabetes improvement achieved with the EndoBarrier Gastrointestinal Liner.

22 Dec 2009

School intervention programs may promote psychological well-being among adolescents

A new study which has been conducted at the University of Bologna shows that brief psychological interventions in school may increase well-being among adolescents and these results persist after 6 months

22 Dec 2009

Women eligible for breast cancer screening with MRI decline to undergo the procedure, study shows

In a new study published in the January issue of Radiology, 42 percent of women eligible for breast cancer screening with MRI declined to undergo the procedure.

22 Dec 2009

Anxiety News and Research

Latest Anxiety News and Research

Majority of long-term cancer survivors do not have access to personalized care services

Study reveals multiple ultrasound scans are more pronounced in low-risk pregnancies

Findings suggest abuse is a risk factor for chronic headache

VELCADE sNDA receives FDA approval

Talampanel slows progression of amyotrophic lateral sclerosis

Impending job cuts raises anxiety at Peterborough Regional Health Centre

WDI utilizes DXA analysis for fitness and weight management programs

Sharing Miracles: A TV program that features inspirational stories of real patients

Ford and MIT explore automotive technology solutions to reduce driver stress

Overview of grief

CORE, a biopsychosocial treatment center for weight loss

First animal model for studying schizophrenia

CAMFT encourages people to focus on emotional health in 2010

Test tube experiments show slight changes in protein chemistry can eliminate Huntington's disease in mice

PHT comments on FDA's PRO Final Guidance

FDA issues Pfizer a Complete Response letter for Lyrica GAD monotherapy treatment

New energy receptor theory of brain function

GI Dynamics' EndoBarrier non-surgical type 2 diabetes therapy receives European CE mark approval

School intervention programs may promote psychological well-being among adolescents

Women eligible for breast cancer screening with MRI decline to undergo the procedure, study shows

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Anxiety News and Research

Latest Anxiety News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in